APO RESEARCH · REPORT
Pathological Examination
A pathomorphological method used to examine pathological changes in organs, tissues or cells. In order to explore the disease process of organs, tissues or cells, some pathomorphological examination method can be used to check the pathological changes, explore the causes, pathogenesis, occurrence and development process of lesions, and finally make pathological diagnosis.
Product & engineering
Understand the product.
A pathomorphological method used to examine pathological changes in organs, tissues or cells. In order to explore the disease process of organs, tissues or cells, some pathomorphological examination method can be used to check the pathological changes, explore the causes, pathogenesis, occurrence and development process of lesions, and finally make pathological diagnosis.
Selected research
Industry Research
Pathological Examination Industry Research Report 2026
Market perspective
A pathomorphological method used to examine pathological changes in organs, tissues or cells. In order to explore the disease process of organs, tissues or cells, some pathomorphological examination method can be used to check the pathological changes, explore the causes, pathogenesis, occurrence and development process of lesions, and finally make pathological diagnosis.
From perspective of type, pathological examination can be split into histopathology, cell pathology, immunohistochemical pathology and molecular pathology. In 2019, cell pathology took up for about 48% market share, which made it the largest segment of global pathological examination.
North America is the largest consumption region of pathological examination, with a consumption market share nearly 37% in 2019. The second place is Asia-Pacific; following North America with the consumption market share over 31% in 2020.
Read the full market overview
Key players of global pathological examination market are Quest Diagnostics, Sonic Healthcare, Lab Corp, Unilabs, SYNLAB International. The top 5 players totally took up a market share of about 18% in 2019. Quest Diagnostics is in the first place, which accounted for above 5% of global market.
Report Scope
This report quantifies the global Pathological Examination market in terms of revenue (US$ million) and, where applicable, service volume (), using 2024 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of service Types and end-use Applications, harmonizes provider attribution, and delivers comparable time series by company, Type, Application, and region or country, including indicative price bands (US$/) and concentration ratios (CR5/CR10). Outputs are intended to support service design, budgeting, capacity planning, and benchmarking for providers, platforms, channel partners, and investors; the report also reviews technology shifts and notable service innovations relevant to Pathological Examination.
Key Companies & Market Share Insights
This section profiles leading service providers with 2021–2025 results and a 2026–2032 outlook—covering revenue, market share, price bands, service portfolio and client mix, regional and channel mix, and key developments (M&A, network expansion, certifications). It also provides global revenue, average price, and—where applicable—volume metrics by provider, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Pathological Examination Market by Company
Quest Diagnostics
Sonic Healthcare
Lab Corp
Unilabs
SYNLAB International
BML
Pathologists Diagnostic
StageBio
KingMed Diagnostics Group
Dian Diagnostics Group
Adicon Clinical Laboratories Inc.
Huayin Health
Pathological Examination Segment by Type
Histopathology
Cytopathology
Immunohistochemical Pathology
Molecular Pathology
Pathological Examination Segment by Application
Hospital
Medical Laboratory
Pathological Examination Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Spain
Russia
Netherlands
Nordic Countries
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Colombia
Middle East & Africa
Saudi Arabia
Israel
United Arab Emirates
Turkey
Iran
Egypt
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Pathological Examination market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Pathological Examination and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Pathological Examination.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Provides the analysis of various market segments product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 6: Detailed analysis of Pathological Examination companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 7, 8, 9, 10, 11: North America, Europe, Asia Pacific, South America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 12: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.
Chapter 13: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Histopathology
- Cytopathology
- Immunohistochemical Pathology
- Molecular Pathology
Applications
- Hospital
- Medical Laboratory
Companies covered
- Quest Diagnostics
- Sonic Healthcare
- Lab Corp
- Unilabs
- SYNLAB International
- BML
- Pathologists Diagnostic
- StageBio
- KingMed Diagnostics Group
- Dian Diagnostics Group
- Adicon Clinical Laboratories Inc.
- Huayin Health
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Pathological Examination by Type
- 2.2.1 Market Value Comparison by Type (2021 VS 2025 VS 2032)
- 2.2.2 Histopathology
- 2.2.3 Cytopathology
- 2.2.4 Immunohistochemical Pathology
- 2.2.5 Molecular Pathology
- 2.3 Pathological Examination by Application
- 2.3.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.3.2 Hospital
- 2.3.3 Medical Laboratory
- 2.4 Assumptions and Limitations
3 Pathological Examination Breakdown Data by Type
- 3.1 Global Pathological Examination Historic Market Size by Type (2021-2026)
- 3.2 Global Pathological Examination Forecasted Market Size by Type (2027-2032)
4 Pathological Examination Breakdown Data by Application
- 4.1 Global Pathological Examination Historic Market Size by Application (2021-2026)
- 4.2 Global Pathological Examination Forecasted Market Size by Application (2027-2032)
5 Global Growth Trends
- 5.1 Global Pathological Examination Market Perspective (2021-2032)
- 5.2 Global Pathological Examination Growth Trends by Region
- 5.2.1 Global Pathological Examination Market Size by Region: 2021 VS 2025 VS 2032
- 5.2.2 Pathological Examination Historic Market Size by Region (2021-2026)
- 5.2.3 Pathological Examination Forecasted Market Size by Region (2027-2032)
- 5.3 Pathological Examination Market Dynamics
- 5.3.1 Pathological Examination Industry Trends
- 5.3.2 Pathological Examination Market Drivers
- 5.3.3 Pathological Examination Market Challenges
- 5.3.4 Pathological Examination Market Restraints
6 Market Competitive Landscape by Players
- 6.1 Global Top Pathological Examination Players by Revenue
- 6.1.1 Global Top Pathological Examination Players by Revenue (2021-2026)
- 6.1.2 Global Pathological Examination Revenue Market Share by Players (2021-2026)
- 6.2 Global Pathological Examination Industry Players Ranking, 2023 VS 2024 VS 2025
- 6.3 Global Key Players of Pathological Examination Head Office and Area Served
- 6.4 Global Pathological Examination Players, Product Type & Application
- 6.5 Global Pathological Examination Manufacturers Established Date
- 6.6 Global Pathological Examination Market CR5 and HHI
- 6.7 Global Players Mergers & Acquisition
7 North America
- 7.1 North America Pathological Examination Market Size (2021-2032)
- 7.2 North America Pathological Examination Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 7.3 North America Pathological Examination Market Size by Country (2021-2026)
- 7.4 North America Pathological Examination Market Size by Country (2027-2032)
- 7.5 United States
- 7.5 United States
- 7.6 Canada
- 7.7 Mexico
8 Europe
- 8.1 Europe Pathological Examination Market Size (2021-2032)
- 8.2 Europe Pathological Examination Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 8.3 Europe Pathological Examination Market Size by Country (2021-2026)
- 8.4 Europe Pathological Examination Market Size by Country (2027-2032)
- 8.5 Germany
- 8.6 France
- 8.7 U.K.
- 8.8 Italy
- 8.9 Spain
- 8.10 Russia
- 8.11 Netherlands
- 8.12 Nordic Countries
9 Asia-Pacific
- 9.1 Asia-Pacific Pathological Examination Market Size (2021-2032)
- 9.2 Asia-Pacific Pathological Examination Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 9.3 Asia-Pacific Pathological Examination Market Size by Country (2021-2026)
- 9.4 Asia-Pacific Pathological Examination Market Size by Country (2027-2032)
- 9.5 China
- 9.6 Japan
- 9.7 South Korea
- 9.8 India
- 9.9 Australia
- 9.10 China Taiwan
- 9.11 Southeast Asia
10 South America
- 10.1 South America Pathological Examination Market Size (2021-2032)
- 10.2 South America Pathological Examination Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 10.3 South America Pathological Examination Market Size by Country (2021-2026)
- 10.4 South America Pathological Examination Market Size by Country (2027-2032)
- 10.5 Brazil
- 10.6 Argentina
- 10.7 Chile
- 10.8 Colombia
- 10.9 Peru
11 Middle East & Africa
- 11.1 Middle East & Africa Pathological Examination Market Size (2021-2032)
- 11.2 Middle East & Africa Pathological Examination Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 11.3 Middle East & Africa Pathological Examination Market Size by Country (2021-2026)
- 11.4 Middle East & Africa Pathological Examination Market Size by Country (2027-2032)
- 11.5 Saudi Arabia
- 11.6 Israel
- 11.7 United Arab Emirates
- 11.8 Turkey
- 11.9 Iran
- 11.10 Egypt
12 Players Profiled
- 12.1 Quest Diagnostics
- 12.1.1 Quest Diagnostics Company Information
- 12.1.2 Quest Diagnostics Business Overview
- 12.1.3 Quest Diagnostics Revenue in Pathological Examination Business (2021-2026)
- 12.1.4 Quest Diagnostics Pathological Examination Product Portfolio
- 12.1.5 Quest Diagnostics Recent Developments
- 12.2 Sonic Healthcare
- 12.2.1 Sonic Healthcare Company Information
- 12.2.2 Sonic Healthcare Business Overview
- 12.2.3 Sonic Healthcare Revenue in Pathological Examination Business (2021-2026)
- 12.2.4 Sonic Healthcare Pathological Examination Product Portfolio
- 12.2.5 Sonic Healthcare Recent Developments
- 12.3 Lab Corp
- 12.3.1 Lab Corp Company Information
- 12.3.2 Lab Corp Business Overview
- 12.3.3 Lab Corp Revenue in Pathological Examination Business (2021-2026)
- 12.3.4 Lab Corp Pathological Examination Product Portfolio
- 12.3.5 Lab Corp Recent Developments
- 12.4 Unilabs
- 12.4.1 Unilabs Company Information
- 12.4.2 Unilabs Business Overview
- 12.4.3 Unilabs Revenue in Pathological Examination Business (2021-2026)
- 12.4.4 Unilabs Pathological Examination Product Portfolio
- 12.4.5 Unilabs Recent Developments
- 12.5 SYNLAB International
- 12.5.1 SYNLAB International Company Information
- 12.5.2 SYNLAB International Business Overview
- 12.5.3 SYNLAB International Revenue in Pathological Examination Business (2021-2026)
- 12.5.4 SYNLAB International Pathological Examination Product Portfolio
- 12.5.5 SYNLAB International Recent Developments
- 12.6 BML
- 12.6.1 BML Company Information
- 12.6.2 BML Business Overview
- 12.6.3 BML Revenue in Pathological Examination Business (2021-2026)
- 12.6.4 BML Pathological Examination Product Portfolio
- 12.6.5 BML Recent Developments
- 12.7 Pathologists Diagnostic
- 12.7.1 Pathologists Diagnostic Company Information
- 12.7.2 Pathologists Diagnostic Business Overview
- 12.7.3 Pathologists Diagnostic Revenue in Pathological Examination Business (2021-2026)
- 12.7.4 Pathologists Diagnostic Pathological Examination Product Portfolio
- 12.7.5 Pathologists Diagnostic Recent Developments
- 12.8 StageBio
- 12.8.1 StageBio Company Information
- 12.8.2 StageBio Business Overview
- 12.8.3 StageBio Revenue in Pathological Examination Business (2021-2026)
- 12.8.4 StageBio Pathological Examination Product Portfolio
- 12.8.5 StageBio Recent Developments
- 12.9 KingMed Diagnostics Group
- 12.9.1 KingMed Diagnostics Group Company Information
- 12.9.2 KingMed Diagnostics Group Business Overview
- 12.9.3 KingMed Diagnostics Group Revenue in Pathological Examination Business (2021-2026)
- 12.9.4 KingMed Diagnostics Group Pathological Examination Product Portfolio
- 12.9.5 KingMed Diagnostics Group Recent Developments
- 12.10 Dian Diagnostics Group
- 12.10.1 Dian Diagnostics Group Company Information
- 12.10.2 Dian Diagnostics Group Business Overview
- 12.10.3 Dian Diagnostics Group Revenue in Pathological Examination Business (2021-2026)
- 12.10.4 Dian Diagnostics Group Pathological Examination Product Portfolio
- 12.10.5 Dian Diagnostics Group Recent Developments
- 12.11 Adicon Clinical Laboratories Inc.
- 12.11.1 Adicon Clinical Laboratories Inc. Company Information
- 12.11.2 Adicon Clinical Laboratories Inc. Business Overview
- 12.11.3 Adicon Clinical Laboratories Inc. Revenue in Pathological Examination Business (2021-2026)
- 12.11.4 Adicon Clinical Laboratories Inc. Pathological Examination Product Portfolio
- 12.11.5 Adicon Clinical Laboratories Inc. Recent Developments
- 12.12 Huayin Health
- 12.12.1 Huayin Health Company Information
- 12.12.2 Huayin Health Business Overview
- 12.12.3 Huayin Health Revenue in Pathological Examination Business (2021-2026)
- 12.12.4 Huayin Health Pathological Examination Product Portfolio
- 12.12.5 Huayin Health Recent Developments
13 Report Conclusion
14 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst